Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:16R-HETE)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004153 AN006895 Multi-omics Study of Small Intestine Adaptation After Total Colectomy in a Rat model Feces Rat Shanghai Jiao Tong University LC-MS
ST004138 AN006860 Variation in microbiome and metabolites are associated with advantageous effects of cholestyramine on primary biliary cholangitis with pruritus Feces Human Autoimmune disease Hangzhou Xixi Hospital LC-MS
ST004138 AN006860 Variation in microbiome and metabolites are associated with advantageous effects of cholestyramine on primary biliary cholangitis with pruritus Feces Human Liver disease Hangzhou Xixi Hospital LC-MS
ST003818 AN006278 Irisin Attenuates Postmenopausal Osteoporosis by Upregulating Phosphatidylcholine Metabolism via the Wnt/β-catenin Pathway Blood Mouse Osteoporosis Huizhou Central People's Hospital LC-MS
ST003817 AN006276 Irisin promotes bone tissue repair and intestinal protection in osteoporotic mice Feces Mouse Osteoporosis Huizhou Central People's Hospital LC-MS
ST003745 AN006150 Screen potential marker proteins influencing spermatogenesis in the testes of Shandong Black Cattle bulls via multi-omics integrated analysis. Testes Cattle Qingdao Agricultural University LC-MS
ST003534 AN005805 Metabolomic analysis of altered arachidonic acid metabolism in mouse heart tissue after myocardial infarction Heart Mouse Cardiovascular disease Tianjin Medical University LC-MS
ST003534 AN005805 Metabolomic analysis of altered arachidonic acid metabolism in mouse heart tissue after myocardial infarction Heart Mouse Inflammation Tianjin Medical University LC-MS
ST003524 AN005787 Arachidonic acid fuels inflammation by unlocking 5-LOX in macrophages after myocardial infarction Blood Human Cardiovascular disease Tianjin Medical University LC-MS
ST003222 AN005283 A small molecule macrophage migration inhibitory factor agonist ameliorates age-related myocardial intolerance to ischemia-reperfusion insults via metabolic regulation - Part 1 Heart Mouse Ischemia University of Mississippi Medical Center LC-MS
ST003050 AN005001 Plasma instead of serum avoids critical confounding of clinical metabolomics studies by platelets (Part 1) Blood Human University of Vienna LC-MS
ST002455 AN004005 Organism-Wide Analysis of Sepsis Reveals Mechanisms of Systemic Inflammation Blood Mouse Sepsis University of Chicago LC-MS
ST002216 AN003625 Non-targeted metabolomics screen comparing metabolite profiles of serum from PDAC-bearing mice that received metronidazole using high-resolution, high-performance LC-MS/MS analysis. Blood Mouse Cancer Wistar Institute LC-MS
ST001951 AN003176 Quantification of ω-3 fatty acids and their derivatives in lungs from hypoxia-induced pulmonary hypertension (PH) mice. Lung Mouse Pulmonary hypertension University of Tokyo LC-MS
ST001856 AN003009 The metabolomic resetting effect of FG4592 in AKI to CKD transition-day 21 (Part 2) Kidney Mouse Kidney disease Children's Hospital of Nanjing Medical University LC-MS
ST001215 AN002026 Effect of Mirabegron Treatment on serum lipidome Blood Human Joslin Diabetes Center LC-MS
ST001214 AN002025 Lipidommics in the serum of human subjects Blood Human Joslin Diabetes Center LC-MS
ST001213 AN002024 Serum lipidomic profile of cold-exposed Ucp1cre/12-LOX KO mice Blood Mouse Joslin Diabetes Center LC-MS
ST001207 AN002009 Lipidomics in the serum of cold exposed mice treated with 12-LOX inhibitor LOXBlock-1 Blood Mouse Joslin Diabetes Center LC-MS
ST001206 AN002008 Effects of cold exposure on serum lipidomic in mice Blood Mouse Joslin Diabetes Center LC-MS
ST001154 AN001945 A comprehensive plasma metabolomics dataset for a cohort of mouse knockouts within the International Mouse Phenotyping Consortium Blood Mouse University of California, Davis GC-MS/LC-MS
ST000916 AN001491 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma Blood Human Fatty liver disease LIPID MAPS GC-MS/LC-MS
ST000915 AN001485 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver Liver Human Fatty liver disease LIPID MAPS GC-MS/LC-MS
ST000004 AN000004 Lipidomics studies on NIDDK / NIST human plasma samples Blood Human LIPID MAPS LC-MS
  logo